Nature Communications· 2013Q1
Evaluating cell lines as tumour models by comparison of genomic profiles
- 1,497citations
- Q1SCImago
- 2013year
Short summary
Researchers identified ovarian cancer cell lines that more closely resemble actual tumour genomic profiles than commonly used lines, proposing them as superior models for cancer research.
AI-generated from the title and abstract; the full text is not read.
Key points
- Commonly used ovarian cancer cell lines show pronounced molecular differences compared to actual tumour samples.
- Several rarely used cell lines exhibit higher genetic similarity to ovarian tumours.
- Genomic comparison of copy-number changes, mutations, and mRNA expression was used.
- The findings suggest a method for selecting more accurate cell line models for cancer research.
AI-generated from the title and abstract; the full text is not read.
Abstract
Cancer cell lines are frequently used as in vitro tumour models. Recent molecular profiles of hundreds of cell lines from The Cancer Cell Line Encyclopedia and thousands of tumour samples from the Cancer Genome Atlas now allow a systematic genomic comparison of cell lines and tumours. Here we analyse a panel of 47 ovarian cancer cell lines and identify those that have the highest genetic similarity to ovarian tumours. Our comparison of copy-number changes, mutations and mRNA expression profiles reveals pronounced differences in molecular profiles between commonly used ovarian cancer cell lines and high-grade serous ovarian cancer tumour samples. We identify several rarely used cell lines that more closely resemble cognate tumour profiles than commonly used cell lines, and we propose these lines as the most suitable models of ovarian cancer. Our results indicate that the gap between cell lines and tumours can be bridged by genomically informed choices of cell line models for all tumour types.
The authors' abstract, as published at the source. Nature Communications, 2013 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Reproductive Medicine
Reproductive MedicineMedicine